|
John C.
Lechleiter, Ph.D., is chairman,
president, and chief executive
officer of Eli Lilly and
Company. Lechleiter served
previously as president and
chief operating officer of
Lilly, beginning in 2005, when
he also joined the board. In
2004, he became Lilly’s
executive vice president for
pharmaceutical operations. Prior
to that, he had served as
executive vice president for
pharmaceutical products and
corporate development since
2001.
Lechleiter
received a bachelor of science
degree in chemistry from Xavier
University (Cincinnati, Ohio) in
1975. He subsequently studied
organic chemistry as a National
Science Foundation Fellow at
Harvard University, where he
received his master’s and
doctorate degrees. In 2006,
Lechleiter received an honorary
doctorate of business
administration from Marian
University (Indianapolis).
Joining Lilly in
1979 as a senior organic chemist
in process research and
development, Lechleiter became
head of that department in 1982.
In 1984, he began serving as
director of pharmaceutical
product development for the
Lilly Research Centre Limited in
Windlesham, England.
He returned to
the United States in 1986 as
manager of research and
development projects for Europe.
In 1988, he became director of
development projects management,
and in 1989, he assumed
additional responsibility for
pharmaceutical regulatory
affairs. In 1991, he was named
executive director of
pharmaceutical product
development, and in 1993, he
became vice president. He was
appointed vice president of
regulatory affairs in 1994. In
1996, he was named vice
president for development and
regulatory affairs. Lechleiter
became senior vice president of
pharmaceutical products in 1998.
He is a member of
the American Chemical Society,
Business Roundtable, and
Business Council. Currently,
Lechleiter serves on the boards
of the Pharmaceutical Research
and Manufacturers of America
(PhRMA); Xavier University;
Fairbanks
Institute (Indianapolis);
Indianapolis Downtown, Inc.; the
Central Indiana Corporate
Partnership; and the United Way
of Central Indiana. He also
serves on the board of Nike,
Inc. |
